BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28988621)

  • 21. Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G.
    Gaza-Bulseco G; Faldu S; Hurkmans K; Chumsae C; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):55-62. PubMed ID: 18567545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
    Hayes JM; Frostell A; Cosgrave EF; Struwe WB; Potter O; Davey GP; Karlsson R; Anneren C; Rudd PM
    J Proteome Res; 2014 Dec; 13(12):5471-85. PubMed ID: 25345863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential influence on antibody dependent cellular phagocytosis by different glycoforms on therapeutic Monoclonal antibodies.
    Kuhns S; Shu J; Xiang C; Guzman R; Zhang Q; Bretzlaff W; Miscalichi N; Kalenian K; Joubert M
    J Biotechnol; 2020 Jun; 317():5-15. PubMed ID: 32361021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding affinities of human IgG1 and chimerized pig and rabbit derivatives to human, pig and rabbit Fc gamma receptor IIIA.
    Bhatti MM; Cai AG; Theunissen JW
    PLoS One; 2019; 14(7):e0219999. PubMed ID: 31323052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The N-linked oligosaccharide at Fc gamma RIIIa Asn-45: an inhibitory element for high Fc gamma RIIIa binding affinity to IgG glycoforms lacking core fucosylation.
    Shibata-Koyama M; Iida S; Okazaki A; Mori K; Kitajima-Miyama K; Saitou S; Kakita S; Kanda Y; Shitara K; Kato K; Satoh M
    Glycobiology; 2009 Feb; 19(2):126-34. PubMed ID: 18952826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
    Thomann M; Schlothauer T; Dashivets T; Malik S; Avenal C; Bulau P; Rüger P; Reusch D
    PLoS One; 2015; 10(8):e0134949. PubMed ID: 26266936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of human monocyte Fc gamma receptors with rat IgG2b. A new indicator for the Fc gamma RIIa (R-H131) polymorphism.
    Haagen IA; Geerars AJ; Clark MR; van de Winkel JG
    J Immunol; 1995 Feb; 154(4):1852-60. PubMed ID: 7836769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM; Kiyoshi M; Tsumoto K
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
    Gurbaxani B; Dostalek M; Gardner I
    Mol Immunol; 2013 Dec; 56(4):660-74. PubMed ID: 23917469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical protein a chromatography as a quantitative tool for the screening of methionine oxidation in monoclonal antibodies.
    Loew C; Knoblich C; Fichtl J; Alt N; Diepold K; Bulau P; Goldbach P; Adler M; Mahler HC; Grauschopf U
    J Pharm Sci; 2012 Nov; 101(11):4248-57. PubMed ID: 22899501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients.
    Thibault G; Paintaud G; Sung HC; Lajoie L; Louis E; The Getaid ; Desvignes C; Watier H; Gouilleux-Gruart V; Ternant D
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential recruitment of activating and inhibitory Fc gamma RII during phagocytosis.
    Syam S; Mero P; Pham T; McIntosh CA; Bruhns P; Booth JW
    J Immunol; 2010 Mar; 184(6):2966-73. PubMed ID: 20154205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes.
    Ramsland PA; Farrugia W; Bradford TM; Sardjono CT; Esparon S; Trist HM; Powell MS; Tan PS; Cendron AC; Wines BD; Scott AM; Hogarth PM
    J Immunol; 2011 Sep; 187(6):3208-17. PubMed ID: 21856937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.
    Lu J; Sun PD
    Immunol Rev; 2015 Nov; 268(1):192-200. PubMed ID: 26497521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of trastuzumab interchain disulfide bond cleavage on Fcγ receptor binding and antibody-dependent tumour cell phagocytosis.
    Suzuki M; Yamanoi A; Machino Y; Ootsubo M; Izawa K; Kohroki J; Masuho Y
    J Biochem; 2016 Jan; 159(1):67-76. PubMed ID: 26254483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tandemly repeated Fc domain augments binding avidities of antibodies for Fcgamma receptors, resulting in enhanced antibody-dependent cellular cytotoxicity.
    Nagashima H; Tezuka T; Tsuchida W; Maeda H; Kohroki J; Masuho Y
    Mol Immunol; 2008 May; 45(10):2752-63. PubMed ID: 18353438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Fcgamma receptor IIa (cd32) gene polymorphism and anti-malarial IgG subclass antibodies to asexual blood-stage antigen of Plasmodium falciparum in an unstable malaria endemic area of Iran.
    Zakeri S; Mashhadi R; Mehrizi AA; Djadid ND
    Exp Parasitol; 2013 May; 134(1):115-21. PubMed ID: 23458236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FcγRII-binding Centyrins mediate agonism and antibody-dependent cellular phagocytosis when fused to an anti-OX40 antibody.
    Zhang D; Whitaker B; Derebe MG; Chiu ML
    MAbs; 2018 Apr; 10(3):463-475. PubMed ID: 29359992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric determination of FcgammaRIIa (CD32) polymorphism.
    van Royen-Kerkhof A; Sanders EA; Wijngaarden S; van Roon JA; Voorhorst-Ogink M; Walraven V; Gerritsen A; van Dijk MA; Kuis W; Rijkers GT; Keler T; Leusen JH; van de Winkel JG
    J Immunol Methods; 2004 Nov; 294(1-2):135-44. PubMed ID: 15604023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a high affinity FcgammaRIIA-binding peptide that distinguishes FcgammaRIIA from FcgammaRIIB and exploits FcgammaRIIA-mediated phagocytosis and degradation.
    Berntzen G; Andersen JT; Ustgård K; Michaelsen TE; Mousavi SA; Qian JD; Kristiansen PE; Lauvrak V; Sandlie I
    J Biol Chem; 2009 Jan; 284(2):1126-35. PubMed ID: 18957413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.